Next Article in Journal
Genome-Wide Identification and Characterization of Pectin Methylesterase Inhibitor Genes in Brassica oleracea
Next Article in Special Issue
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Previous Article in Journal
Altered Expression of Retinol Metabolism-Related Genes in an ANIT-Induced Cholestasis Rat Model
Previous Article in Special Issue
Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach
 
 
Review

The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor

1
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 426, Houston, TX 77030-4009, USA
2
Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(11), 3339; https://doi.org/10.3390/ijms19113339
Received: 2 October 2018 / Revised: 22 October 2018 / Accepted: 23 October 2018 / Published: 26 October 2018
(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
Peroxisome proliferator-activated receptor-delta (PPAR-δ), one of three members of the PPAR group in the nuclear receptor superfamily, is a ligand-activated transcription factor. PPAR-δ regulates important cellular metabolic functions that contribute to maintaining energy balance. PPAR-δ is especially important in regulating fatty acid uptake, transport, and β-oxidation as well as insulin secretion and sensitivity. These salutary PPAR-δ functions in normal cells are thought to protect against metabolic-syndrome-related diseases, such as obesity, dyslipidemia, insulin resistance/type 2 diabetes, hepatosteatosis, and atherosclerosis. Given the high clinical burden these diseases pose, highly selective synthetic activating ligands of PPAR-δ were developed as potential preventive/therapeutic agents. Some of these compounds showed some efficacy in clinical trials focused on metabolic-syndrome-related conditions. However, the clinical development of PPAR-δ agonists was halted because various lines of evidence demonstrated that cancer cells upregulated PPAR-δ expression/activity as a defense mechanism against nutritional deprivation and energy stresses, improving their survival and promoting cancer progression. This review discusses the complex relationship between PPAR-δ in health and disease and highlights our current knowledge regarding the different roles that PPAR-δ plays in metabolism, inflammation, and cancer. View Full-Text
Keywords: PPAR-δ; β-oxidation metabolism; inflammation; cancer PPAR-δ; β-oxidation metabolism; inflammation; cancer
Show Figures

Figure 1

MDPI and ACS Style

Liu, Y.; Colby, J.K.; Zuo, X.; Jaoude, J.; Wei, D.; Shureiqi, I. The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor. Int. J. Mol. Sci. 2018, 19, 3339. https://doi.org/10.3390/ijms19113339

AMA Style

Liu Y, Colby JK, Zuo X, Jaoude J, Wei D, Shureiqi I. The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor. International Journal of Molecular Sciences. 2018; 19(11):3339. https://doi.org/10.3390/ijms19113339

Chicago/Turabian Style

Liu, Yi, Jennifer K. Colby, Xiangsheng Zuo, Jonathan Jaoude, Daoyan Wei, and Imad Shureiqi. 2018. "The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor" International Journal of Molecular Sciences 19, no. 11: 3339. https://doi.org/10.3390/ijms19113339

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop